We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Improving the Speed and Cost-Efficiency of Drug Discovery
News

Improving the Speed and Cost-Efficiency of Drug Discovery

Improving the Speed and Cost-Efficiency of Drug Discovery
News

Improving the Speed and Cost-Efficiency of Drug Discovery

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Improving the Speed and Cost-Efficiency of Drug Discovery"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Optibrium announced a collaboration with MolPort to offer StarDrop™ users fully integrated access to MolPort’s drug discovery database, which consists of 6.3 million commercially available screening compounds and chemical building blocks via its curated collection of catalogues from major chemical suppliers. The latest in a series of recent partnerships with commercial providers, this link with MolPort further extends StarDrop’s capabilities to improve the speed, efficiency, and productivity of the drug discovery process. 

MolPort specialises in the sourcing, and effective single supplier access, of chemicals for drug discovery. From a collection of curated catalogues from all major suppliers, MolPort has created a marketplace and order fulfilment platform for commercially available chemistries which includes 6.7 million high-throughput screening (HTS) compounds. 

StarDrop users can access the MolPort database to quickly search for commercially available screening compounds and reagents. The free link enables users to not only look for exact chemical matches but also select compounds based on similarity to the chemistry of interest.  This provides an invaluable tool for chemists to easily enrich their understanding of structure–activity relationships (SAR) in a project’s chemistry. MolPort’s compound search results are presented directly in StarDrop, where its unique capabilities for analysis of SAR and compound optimisation guide the selection of compounds with an improved chance of success.

Dr Matthew Segall, CEO of Optibrium, commented: “We are pleased to be working with MolPort in our latest collaboration with leading providers in drug discovery and wider chemistry fields. MolPort specialises in sourcing large numbers of chemicals from an array of large and the more niche suppliers and StarDrop users can now benefit from seamless access to some 6.3 million screening compounds and building blocks.”

Dr Imants Zudans, CEO of MolPort said: “Over 85% of product inventory listed in the MolPort database is synchronised daily with suppliers. StarDrop users gain direct access to these up-to-date data and can have a very high degree of confidence that all samples can be ordered immediately from MolPort, reducing design-test cycle times.”

Source:

Story from Optbrium. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.

Advertisement